META vs NBIX · P/E 29, rev $200.97B vs P/E 45, rev $2.36B
Meta Platforms Inc. (META) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Meta Platforms Inc. (META) is a internet content & information company listed on US. It is led by Mark Zuckerberg.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported META revenue for 2025-12-31 was $200.97B. Net income was $60.46B. Revenue was up 22.2% from 2024-12-31 to 2025-12-31. META currently screens at market cap $1.64T and trailing P/E 28.8.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
META currently screens at market cap $1.64T and trailing P/E 28.8. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the META and NBIX stock pages for the full models.
Not investment advice.